id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-V-2344-0003,FDA,FDA-2020-V-2344,Variance Approval Letter to Joshua Coonradt from FDA CDRH,Other,Approval for Variance (VRA),2021-02-19T05:00:00Z,2021,2,2021-02-19T05:00:00Z,,2021-02-19T16:38:32Z,,0,0,0900006484a439b8
FDA-2020-V-2344-0002,FDA,FDA-2020-V-2344,Acknowledgment Letter from FDA DMS to Joshua Coonradt,Other,Acknowledgement Letter/Receipt,2020-12-29T05:00:00Z,2020,12,2020-12-29T05:00:00Z,,2020-12-29T18:17:52Z,,0,0,09000064849cb386
FDA-2020-V-2344-0001,FDA,FDA-2020-V-2344,Variance Application from Joshua Coonradt,Other,Application for Variance (VAR),2020-12-29T05:00:00Z,2020,12,2020-12-29T05:00:00Z,,2020-12-29T18:17:30Z,,0,0,09000064849cb2cb